In order for our site to display correctly you will need a newer version of your web browser.
The following browsers support numerous web standards including CSS,XHTML, and the DOM (a universal means of controlling the behavior of web pages):
- Netscape v7 or higher (all platforms), Mozilla FireFox (Windows), Camino (Mac OS X), Galeon (Linux GNOME Desktop) or other browser stemming from the Mozilla.org project.
- Opera v7 or higher (Windows, Linux)
- Apple's Safari (Mac OS X)
- Konqueror (Linux KDE Desktop)
- Microsoft Internet Explorer v6 or higher (Windows) or v5 or higher (Macintosh)
Please note that this is not intended be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Finding Cures. Saving Children.
Daniel M. Green, MD
Member, St. Jude Faculty
Departments
Epidemiology and Cancer Control
Oncology
Divisions
Cancer Survivorship
Contact Information
Daniel M. Green, MD
Epidemiology and Cancer Control
MS 735
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: daniel.green@stjude.org
Phone: (901) 595-5915
FAX: (901) 595-5845
Education
BS - Massachusetts Institute of Technology Cambridge, Massachusetts (1969)MD - St. Louis University School of Medicine, St. Louis, Missouri (1973)
Research Interests
-
Late effects of treatment for childhood cancer, particularly fertility and pregnancy outcome, cardiac disease and second malignant neoplasms.
-
Treatment of Wilms tumor
Current Research
SJLIFE, Study Committee
St. Jude Consortium for Interventional Research, Chairman
Selected Publications
Klosky JL, Gamble HL, Spunt SS, Randolph-Frye ME, Green DM, Hudson MM, Human papillomavirus (HPV) vaccination in survivors of childhood cancer. Cancer 2009 (in press).
Sredni ST, Gadd S, Huang C-C, Breslow N, Grundy P, Green DM, Dome JS, Perlman EJ. Subsets of very low risk Wilms tumors show distinctive gene expression, histologic, and clinical features. Clin Cancer Res 2009 (in press).
Warwick AB, Kalapurakal JA, Ou S-S, Green DM, Norkool PA, Peterson SM, Breslow NE Portal hypertension in children with Wilms tumor: a report from the National Wilms Tumor Study Group. Int J Rad Oncol Biol Phys 2009 (in press).
Wright KD, Green DM, Daw NJ. Late effects of treatment for Wilms tumor. Pediatr Hematol Oncol 2009 (in press).
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL. Fertility of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 27:2677–85, 2009.
Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, Stovall M, Yasui Y. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol 27:2374–81, 2009.
Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, Green DM, Hammond S, Meadows AT, Mertens AC, Mulvihill JJ, Nathan PC, Neglia JP, Packer RJ, Rajaraman P, Sklar CA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. The Childhood Cancer Survivor Study: a National Cancer Institute–supported resource for outcome and intervention research. J Clin Oncol 27:2308–18, 2009.
Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC, Neglia JP, Meadows AT, Robison LL. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol 27:2405–14, 2009.
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, Thomas PR, Grundy P, Green DM, D’Angio GJ. Intraoperative spillage of favorable histology Wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. a report from the national Wilms tumor study group. Int J Radiat Oncol Biol Phys 2009 Apr 21. [Epub ahead of print]
Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE, Green DM, Fritsch MK, Perlman EJ. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res 5:1770–8, 2009.
Fernandez CV, Anderson J, Breslow NE, Dome JS, Grundy PE, Perlman EJ, Green DM; National Wilms Tumor Study Group/Children’s Oncology Group. Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2:254–8, 2009.
Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A III, von Hoff D, Schuchter LM. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127–45, 2009.
Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, Robison LL, Mertens AC. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS). Sleep 31:27–81, 2008.
Green DM. Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors. J Clin Oncol 26:3297–8, 2008.
Feusner JH, Ritchey ML, Norkool PA, Takashima JR, Breslow NE, Green DM. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 50:242–5, 2008.
Malogolowkin M, Cotton CA, Math M, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PRM, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Robert Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 50:236-41, 2008.
Green DM. Controversies in the management of Wilms tumour -- immediate nephrectomy or delayed nephrectomy? Eur J Cancer 43:2453-6, 2007.
Lawless SCW, Verma P, Green DM, Mahoney MC. Mortality experiences among 15+ year survivors of childhood and adolescent cancers. Pediatr Blood Cancer 48:333-8, 2007.
Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PRM, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Robert Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 48:493-9, 2007.
Breslow NE, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, Thomas PRM, D'Angio GJ, Green, DM. Radiation therapy for favorable histology Wilms tumor: Prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4. Int J Rad Oncol Biol Phys 65:203-9, 2006.
Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin MH, Beckwith JB, Shamberger RS, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green D. Treatment of anaplastic histology Wilms' Tumor: Results from the Fifth National National Wilms' Tumor Study. J Clin Oncol 24:2352-8, 2006.
Perlman EJ, Faria P, Soares A, Hoffer F, Sredni S, Ritchey M, Shamberger RC, Green D, Beckwith JB. Hyperplastic perilobar nephroblastomatosis: Long term survival of 52 patients. Pediatr Blood Cancer 46:203-21, 2006.
Shamberger RC, Haase GM, Argani P, Perlman EJ, Cotton CA, Takashima J, Green DM, Ritchey ML. Bilateral Wilms tumors with progressive or nonresponsive disease. J Pediatr Surg 41:652-7, 2006.
Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL. Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:890-6, 2006.
Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 174:1972-5, 2005.
Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Hamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PRM, Macklis R, Tomlinson G, Huff V, Green DM. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor. a report from the National Wilms Tumor Study Group. J Clin Oncol 23:7312-21, 2005.
Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S, Thomas PRM, Perlman E, Beckwith JB, D'Angio GJ, Green DM. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol 23:7641–5, 2005.
Last updated: June 2009
